FREE SHIPPING ON ORDERS OVER $150

glutathione adduct toxicity of the and carcinogenicity of AFB1. GSH, Glutathione-Mediated Conjugation of Anticancer Drugs

$29.17

Quantity
- +
Description

Chem, 269, 2787627884

glutathione adduct toxicity of the and carcinogenicity of AFB1. GSH, Glutathione-Mediated Conjugation of Anticancer Drugs

These changes in body composition were accompanied by elevated plasma insulin levels in sCT-treated KO mice, an effect not observed with cagrilintide possibly indicating a prediabetic state

glutathione adduct toxicity of the and carcinogenicity of AFB1. GSH, Glutathione-Mediated Conjugation of Anticancer Drugs

doi: 10.3389/fnut.2025.1650328 Received 19 June 2025 Accepted 20 August 2025 Published 03 September 2025 Volume 12 - 2025 Edited by Karolina Wojtunik-Kulesza, Medical University of Lublin, Poland Reviewed by Sara Luz Morales-Lzaro, National Autonomous University of Mexico, Mexico Rogrio Saad Vaz, Federal University of Paran, Brazil Anna Oniszczuk, Doctoral School of Medical University of Lublin, Poland Updates Copyright 2025 Ye, Sun, He, Ai, Jin and Abd El-Aty

glutathione adduct toxicity of the and carcinogenicity of AFB1. GSH, Glutathione-Mediated Conjugation of Anticancer Drugs

JCI Insight 1 , e86326 (2016)

glutathione adduct toxicity of the and carcinogenicity of AFB1. GSH, Glutathione-Mediated Conjugation of Anticancer Drugs

Electron Physician 8 (8), 27192725

glutathione adduct toxicity of the and carcinogenicity of AFB1. GSH, Glutathione-Mediated Conjugation of Anticancer Drugs

You may also like

recommand products